Oxidized-LDL enhances coronary vasoconstriction by increasing the activityof protein kinase C isoforms alpha and epsilon

Citation
Jb. Giardina et al., Oxidized-LDL enhances coronary vasoconstriction by increasing the activityof protein kinase C isoforms alpha and epsilon, HYPERTENSIO, 37(2), 2001, pp. 561-568
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
HYPERTENSION
ISSN journal
0194911X → ACNP
Volume
37
Issue
2
Year of publication
2001
Part
2
Supplement
S
Pages
561 - 568
Database
ISI
SICI code
0194-911X(200102)37:2<561:OECVBI>2.0.ZU;2-L
Abstract
Oxidized low-density lipoprotein (ox-LDL) plays a critical role in the deve lopment of atherosclerotic coronary vasospasm; however, the cellular mechan isms involved are not fully understood. We tested the hypothesis that ox-LD L enhances coronary vasoconstriction by increasing the activity of specific protein kinase C (PKC) isoforms in coronary smooth muscle. Active stress w as measured in de-endothelialized porcine coronary artery strips; cell cont raction and [Ca2+](i) were monitored in single coronary smooth muscle cells loaded with fura-2; and the cytosolic and particulate fractions were exami ned for PKC activity and reactivity with isoform-specific anti-PKC antibodi es with Western blots. Ox-LDL (100 mug/mL) caused slow but significant incr eases in active stress to 1.3+/-0.4X10(3) N/m(2) and cell contraction (10%) that were completely inhibited by GF109203X (10(-6) mol/L), an inhibitor o f Ca2+-dependent and -independent PKC isoforms, with no significant change in [Ca2+](i). 5-Hydroxytryptamine (5-HT: 10(-7) mol/L) and KCl (24 mmol/L) caused increases in cell contraction and [Ca2+](i) that were inhibited by t he Ca2+ channel blocker verapamil (10(-6) mol/L). Ox-LDL enhanced coronary contraction to 5-HT and KCl with no additional increases in [Ca2+](i). Dire ct activation of PKC by phorbol 12-myristate 13-acetate (PMA; 10(-7) mol/L) caused a contraction similar in magnitude and time course to ox-LDL-induce d contraction and enhanced 5-HT- and KCl-induced contraction with no additi onal increases in [Ca2+](i). The ox-LDL-induced enhancement of 5-HT and KCl contraction was inhibited by Go6976 (10-6 mol/L), an inhibitor of Ca2+-dep endent PKC isoforms. Both ox-LDL and PMA caused an increase in PKC activity in the particulate fraction, a decrease in the cytosolic fraction, and an increase in the particulate/cytosolic PKC activity ratio. Western blots rev ealed the Ca2+-dependent PKC-alpha and the Ca2+-independent PKC-delta, -eps ilon, and -zeta isoforms. In unstimulated tissues, PKC-alpha- and -epsilon were mainly cytosolic, PKC-delta was mainly in the particulate fraction, an d PKC-zeta was equally distributed in the cytosolic and particulate fractio ns. Ox-LDL alone or PMA alone caused translocation of PKC-epsilon from the cytosolic to particulate fraction, whereas the distribution pattern of PKC- alpha, -delta, and -zeta remained unchanged. 5-HT (10(-7) mol/L) alone and KCl alone did not change PKC activity. In tissues pretreated with ox-LDL or PMA, 5-HT and KCl caused additional increases in PKC-alpha activity. Nativ e LDL did not significantly affect coronary contraction, [Ca2+](i), or PKC activity. These results suggest that ox-LDL causes coronary contraction via activation of the Ca2+-independent PKC-epsilon and enhances the contractio n to [Ca2+](i)-increasing agonists by activating the Ca2+-dependent PKC-alp ha. Activation of PKC-alpha and -epsilon may represent a possible cellular mechanism by which ox-LDL could enhance coronary vasospasm.